nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinolazepam—GABRA3—Graves' disease	0.879	1	CbGaD
Cinolazepam—GABRG3—GABA A receptor activation—GABRA3—Graves' disease	0.00476	0.0468	CbGpPWpGaD
Cinolazepam—GABRB1—GABA A receptor activation—GABRA3—Graves' disease	0.00469	0.0461	CbGpPWpGaD
Cinolazepam—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00401	0.0394	CbGpPWpGaD
Cinolazepam—GABRA5—GABA A receptor activation—GABRA3—Graves' disease	0.00389	0.0383	CbGpPWpGaD
Cinolazepam—GABRA2—GABA A receptor activation—GABRA3—Graves' disease	0.00376	0.037	CbGpPWpGaD
Cinolazepam—GABRB3—GABA A receptor activation—GABRA3—Graves' disease	0.00373	0.0367	CbGpPWpGaD
Cinolazepam—GABRR1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00371	0.0365	CbGpPWpGaD
Cinolazepam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00366	0.0361	CbGpPWpGaD
Cinolazepam—GABRR2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00354	0.0348	CbGpPWpGaD
Cinolazepam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.0032	0.0315	CbGpPWpGaD
Cinolazepam—GABRG3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00292	0.0287	CbGpPWpGaD
Cinolazepam—GABRB1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00287	0.0283	CbGpPWpGaD
Cinolazepam—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00245	0.0241	CbGpPWpGaD
Cinolazepam—GABRA5—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00238	0.0235	CbGpPWpGaD
Cinolazepam—GABRA2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.0023	0.0226	CbGpPWpGaD
Cinolazepam—GABRB3—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00229	0.0225	CbGpPWpGaD
Cinolazepam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00224	0.0221	CbGpPWpGaD
Cinolazepam—GABRR1—GABA receptor activation—GABRA3—Graves' disease	0.00197	0.0194	CbGpPWpGaD
Cinolazepam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00196	0.0193	CbGpPWpGaD
Cinolazepam—GABRR2—GABA receptor activation—GABRA3—Graves' disease	0.00188	0.0185	CbGpPWpGaD
Cinolazepam—GABRG3—GABA receptor activation—GABRA3—Graves' disease	0.00155	0.0152	CbGpPWpGaD
Cinolazepam—GABRB1—GABA receptor activation—GABRA3—Graves' disease	0.00152	0.015	CbGpPWpGaD
Cinolazepam—GABRR3—eye—Graves' disease	0.00134	0.129	CbGeAlD
Cinolazepam—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.0013	0.0128	CbGpPWpGaD
Cinolazepam—GABRA5—GABA receptor activation—GABRA3—Graves' disease	0.00126	0.0124	CbGpPWpGaD
Cinolazepam—GABRA2—GABA receptor activation—GABRA3—Graves' disease	0.00122	0.012	CbGpPWpGaD
Cinolazepam—GABRB3—GABA receptor activation—GABRA3—Graves' disease	0.00121	0.0119	CbGpPWpGaD
Cinolazepam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.00119	0.0117	CbGpPWpGaD
Cinolazepam—GABRR2—eye—Graves' disease	0.00117	0.112	CbGeAlD
Cinolazepam—GABRR1—eye—Graves' disease	0.00112	0.108	CbGeAlD
Cinolazepam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.00104	0.0102	CbGpPWpGaD
Cinolazepam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000905	0.00891	CbGpPWpGaD
Cinolazepam—GABRG3—Orphan transporters—GABRA3—Graves' disease	0.000902	0.00888	CbGpPWpGaD
Cinolazepam—GABRB1—Orphan transporters—GABRA3—Graves' disease	0.000888	0.00874	CbGpPWpGaD
Cinolazepam—GABRG3—pituitary gland—Graves' disease	0.000874	0.0842	CbGeAlD
Cinolazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000863	0.0085	CbGpPWpGaD
Cinolazepam—GABRR1—Ion channel transport—GABRA3—Graves' disease	0.000805	0.00793	CbGpPWpGaD
Cinolazepam—GABRR2—Ion channel transport—GABRA3—Graves' disease	0.000768	0.00756	CbGpPWpGaD
Cinolazepam—Clorazepate—GABRA3—Graves' disease	0.000761	0.0903	CrCbGaD
Cinolazepam—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.000759	0.00747	CbGpPWpGaD
Cinolazepam—GABRA5—Orphan transporters—GABRA3—Graves' disease	0.000738	0.00726	CbGpPWpGaD
Cinolazepam—GABRA2—Orphan transporters—GABRA3—Graves' disease	0.000712	0.007	CbGpPWpGaD
Cinolazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000711	0.007	CbGpPWpGaD
Cinolazepam—GABRB3—Orphan transporters—GABRA3—Graves' disease	0.000707	0.00696	CbGpPWpGaD
Cinolazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.0007	0.00689	CbGpPWpGaD
Cinolazepam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000694	0.00683	CbGpPWpGaD
Cinolazepam—Alprazolam—GABRA3—Graves' disease	0.000689	0.0817	CrCbGaD
Cinolazepam—GABRR1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00068	0.0067	CbGpPWpGaD
Cinolazepam—GABRB1—pituitary gland—Graves' disease	0.000675	0.0651	CbGeAlD
Cinolazepam—Quazepam—GABRA3—Graves' disease	0.000668	0.0792	CrCbGaD
Cinolazepam—GABRR2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000649	0.00639	CbGpPWpGaD
Cinolazepam—GABRG3—Ion channel transport—GABRA3—Graves' disease	0.000633	0.00623	CbGpPWpGaD
Cinolazepam—Flunitrazepam—GABRA3—Graves' disease	0.000631	0.0748	CrCbGaD
Cinolazepam—GABRB1—Ion channel transport—GABRA3—Graves' disease	0.000623	0.00613	CbGpPWpGaD
Cinolazepam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000607	0.00597	CbGpPWpGaD
Cinolazepam—GABRP—pituitary gland—Graves' disease	0.000605	0.0583	CbGeAlD
Cinolazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000599	0.00589	CbGpPWpGaD
Cinolazepam—Estazolam—GABRA3—Graves' disease	0.00059	0.07	CrCbGaD
Cinolazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000581	0.00572	CbGpPWpGaD
Cinolazepam—Halazepam—GABRA3—Graves' disease	0.000573	0.068	CrCbGaD
Cinolazepam—Adinazolam—GABRA3—Graves' disease	0.000562	0.0666	CrCbGaD
Cinolazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000561	0.00552	CbGpPWpGaD
Cinolazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000557	0.00549	CbGpPWpGaD
Cinolazepam—Fludiazepam—GABRA3—Graves' disease	0.000556	0.066	CrCbGaD
Cinolazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000547	0.00539	CbGpPWpGaD
Cinolazepam—Prazepam—GABRA3—Graves' disease	0.000543	0.0644	CrCbGaD
Cinolazepam—GABRA3—thyroid gland—Graves' disease	0.000539	0.0519	CbGeAlD
Cinolazepam—GABRG3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000535	0.00526	CbGpPWpGaD
Cinolazepam—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000533	0.00524	CbGpPWpGaD
Cinolazepam—GABRB3—eye—Graves' disease	0.000527	0.0508	CbGeAlD
Cinolazepam—GABRB1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000527	0.00518	CbGpPWpGaD
Cinolazepam—GABRR1—Neuronal System—GABRA3—Graves' disease	0.000521	0.00513	CbGpPWpGaD
Cinolazepam—GABRA5—Ion channel transport—GABRA3—Graves' disease	0.000517	0.00509	CbGpPWpGaD
Cinolazepam—GABRG2—pituitary gland—Graves' disease	0.00051	0.0491	CbGeAlD
Cinolazepam—GABRB3—connective tissue—Graves' disease	0.000508	0.049	CbGeAlD
Cinolazepam—Flurazepam—GABRA3—Graves' disease	0.000506	0.0601	CrCbGaD
Cinolazepam—Triazolam—GABRA3—Graves' disease	0.000506	0.06	CrCbGaD
Cinolazepam—GABRA2—Ion channel transport—GABRA3—Graves' disease	0.000499	0.00491	CbGpPWpGaD
Cinolazepam—GABRR2—Neuronal System—GABRA3—Graves' disease	0.000497	0.00489	CbGpPWpGaD
Cinolazepam—GABRB3—Ion channel transport—GABRA3—Graves' disease	0.000496	0.00488	CbGpPWpGaD
Cinolazepam—Oxazepam—GABRA3—Graves' disease	0.00049	0.0582	CrCbGaD
Cinolazepam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000487	0.00479	CbGpPWpGaD
Cinolazepam—Temazepam—GABRA3—Graves' disease	0.000484	0.0574	CrCbGaD
Cinolazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000478	0.00471	CbGpPWpGaD
Cinolazepam—Midazolam—GABRA3—Graves' disease	0.00047	0.0557	CrCbGaD
Cinolazepam—GABRA2—adipose tissue—Graves' disease	0.000464	0.0447	CbGeAlD
Cinolazepam—GABRE—pituitary gland—Graves' disease	0.000462	0.0445	CbGeAlD
Cinolazepam—GABRE—adipose tissue—Graves' disease	0.00046	0.0443	CbGeAlD
Cinolazepam—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00045	0.00443	CbGpPWpGaD
Cinolazepam—GABRA5—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000437	0.0043	CbGpPWpGaD
Cinolazepam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000426	0.00419	CbGpPWpGaD
Cinolazepam—GABRA2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000422	0.00415	CbGpPWpGaD
Cinolazepam—GABRB3—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000419	0.00412	CbGpPWpGaD
Cinolazepam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000412	0.00405	CbGpPWpGaD
Cinolazepam—GABRG3—Neuronal System—GABRA3—Graves' disease	0.00041	0.00403	CbGpPWpGaD
Cinolazepam—GABRB1—Neuronal System—GABRA3—Graves' disease	0.000403	0.00397	CbGpPWpGaD
Cinolazepam—Diazepam—GABRA3—Graves' disease	0.000402	0.0477	CrCbGaD
Cinolazepam—GABRE—thyroid gland—Graves' disease	0.000398	0.0384	CbGeAlD
Cinolazepam—GABRB3—pituitary gland—Graves' disease	0.000391	0.0377	CbGeAlD
Cinolazepam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.00036	0.00354	CbGpPWpGaD
Cinolazepam—GABRB2—Neuronal System—GABRA3—Graves' disease	0.000345	0.00339	CbGpPWpGaD
Cinolazepam—GABRB3—thyroid gland—Graves' disease	0.000337	0.0325	CbGeAlD
Cinolazepam—GABRA5—Neuronal System—GABRA3—Graves' disease	0.000335	0.0033	CbGpPWpGaD
Cinolazepam—GABRA2—Neuronal System—GABRA3—Graves' disease	0.000323	0.00318	CbGpPWpGaD
Cinolazepam—GABRB3—Neuronal System—GABRA3—Graves' disease	0.000321	0.00316	CbGpPWpGaD
Cinolazepam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000315	0.0031	CbGpPWpGaD
Cinolazepam—GABRR1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00028	0.00276	CbGpPWpGaD
Cinolazepam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000276	0.00271	CbGpPWpGaD
Cinolazepam—GABRR2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000267	0.00263	CbGpPWpGaD
Cinolazepam—GABRG3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00022	0.00217	CbGpPWpGaD
Cinolazepam—GABRB1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000217	0.00213	CbGpPWpGaD
Cinolazepam—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000185	0.00182	CbGpPWpGaD
Cinolazepam—GABRA5—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00018	0.00177	CbGpPWpGaD
Cinolazepam—GABRA2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000174	0.00171	CbGpPWpGaD
Cinolazepam—GABRB3—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000173	0.0017	CbGpPWpGaD
Cinolazepam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.00017	0.00167	CbGpPWpGaD
Cinolazepam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	0.000148	0.00146	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	8.61e-05	0.000848	CbGpPWpGaD
Cinolazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	6.25e-05	0.000615	CbGpPWpGaD
